NAGE
Niagen Bioscience, Inc.
3.00$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.8% | +21.1% | -2.1% | +48.8% | +46.7% | +28.0% | +13.8% | +6.8% | +16.0% | +19.2% | +29.9% | |
| – | +3.6% | +8.9% | -4.9% | +44.6% | +32.4% | +16.9% | +8.2% | +12.7% | +12.1% | +15.9% | +21.6% | |
| – | +41.5% | +37.9% | +0.8% | +53.2% | +60.5% | +36.9% | +17.6% | +3.2% | +18.7% | +21.3% | +35.1% | |
| – | +73.6% | +182.9% | +58.8% | +36.7% | -19.3% | -22.7% | +12.2% | +25.9% | +2.7% | +21.3% | +5.2% | |
| – | -8.4% | +28.0% | +91.5% | +53.8% | +26.4% | -10.3% | +18.2% | -22.2% | -11.7% | -26.4% | +47.2% | |
| – | -9.1% | +38.5% | +102.0% | +83.3% | +15.9% | -3.4% | +24.4% | -10.4% | -8.2% | -4.5% | +27.9% | |
| – | – | – | – | – | – | – | – | – | – | – | +85.0% | |
| – | +287.8% | -39.6% | -58.9% | -48.4% | +972.2% | -91.6% | -22.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +105.4% | |
| – | – | – | – | – | – | – | – | – | – | – | +165.6% | |
| – | – | – | – | – | – | – | – | – | – | – | +103.3% | |
| – | – | – | – | – | – | – | – | – | – | – | +90.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.